Point72 Asset Management
MIRM icon

Point72 Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Point72 Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.1M Buy
346,991
+156,353
+82% +$14.7M 0.04% 572
2025
Q4 		$15.1M Sell
190,638
-600,037
-76% -$43.1M 0.02% 1092
2025
Q3 		$58M Buy
790,675
+531,809
+205% +$33.8M 0.1% 235
2025
Q2 		$13.2M Buy
258,866
+26,768
+12% +$1.19M 0.03% 636
2025
Q1 		$10.5M Buy
+232,098
New +$10.9M 0.02% 668
2023
Q3 		– Sell
-601,038
Closed -$15.5M – 2725
2023
Q2 		$15.5M Buy
601,038
+43,600
+8% +$1.16M 0.05% 456
2023
Q1 		$13.4M Buy
557,438
+217,928
+64% +$4.97M 0.04% 464
2022
Q4 		$6.62M Buy
+339,510
New +$6.71M 0.02% 677
2022
Q2 		– Sell
-153,389
Closed -$3.38M – 1540
2022
Q1 		$3.38M Sell
153,389
-161,454
-51% -$3.29M 0.01% 782
2021
Q4 		$5.02M Buy
314,843
+170,443
+118% +$2.65M 0.02% 667
2021
Q3 		$2.88M Buy
144,400
+125,600
+668% +$2.04M 0.01% 747
2021
Q2 		$325K Buy
18,800
+13,800
+276% +$247K ﹤0.01% 889
2021
Q1 		$99K Buy
+5,000
New +$95.7K ﹤0.01% 906
2020
Q3 		– Sell
-97,415
Closed -$1.9M – 1026
2020
Q2 		$1.9M Buy
+97,415
New +$1.63M 0.01% 601

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Point72 Asset Management's MIRM Position: Q1 2026 in Review

Point72 Asset Management increased its Mirum Pharmaceuticals (MIRM) stake by 82% in Q1 2026, buying an estimated $14.7M and bringing the position to 346,991 shares worth $32.1M. The position accounts for 0.04% of the portfolio, ranked #572.

Point72 Asset Management first reported a position in MIRM in Q2 2020 and has held it in 14 quarters since. The position peaked at $58M in Q3 2025. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Point72 Asset Management held 346,991 shares of Mirum Pharmaceuticals worth $32.1M as of Q1 2026.
  • Point72 Asset Management bought 156,353 Mirum Pharmaceuticals shares in Q1 2026, an estimated $14.7M.
  • Mirum Pharmaceuticals made up 0.04% of Point72 Asset Management's portfolio in Q1 2026, its #572 holding.
  • Point72 Asset Management first reported a position in Mirum Pharmaceuticals in Q2 2020 and has held it in 14 quarters since.
  • Point72 Asset Management's Mirum Pharmaceuticals position peaked at $58M in Q3 2025.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.